Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nelson Hayes

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
BMC Gastroenterology|September 26, 2020
Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infectionNaoyuki Ueda, Tomokazu Kawaoka, Michio Imamura, et al.
Gastroenterology|July 20, 2010
ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patientsHidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2015
Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patientsEisuke Miyaki, Michio Imamura, Nobuhiko Hiraga, et al.
The American Journal of Pathology|March 21, 2015
Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized miceYuji Ishida, Chihiro Yamasaki, Ami Yanagi, et al.
Journal of Medical Virology|July 9, 2011
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral stateHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
The Journal of Infectious Diseases|June 16, 2011
Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric miceMasataka Tsuge, Shoichi Takahashi, Nobuhiko Hiraga, et al.
Gut|November 12, 2010
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapyC Nelson Hayes, Mariko Kobayashi, Norio Akuta, et al.
Journal of Medical Virology|May 9, 2015
Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapySatoshi Yoshimi, Michio Imamura, Eisuke Murakami, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virusNobuhiko Hiraga, Hiromi Abe, Michio Imamura, et al.
Journal of Virology|August 7, 2015
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG MiceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
BMC Gastroenterology|September 26, 2020
Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infectionNaoyuki Ueda, Tomokazu Kawaoka, Michio Imamura, et al.
Gastroenterology|July 20, 2010
ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patientsHidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2015
Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patientsEisuke Miyaki, Michio Imamura, Nobuhiko Hiraga, et al.
The American Journal of Pathology|March 21, 2015
Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized miceYuji Ishida, Chihiro Yamasaki, Ami Yanagi, et al.
Journal of Medical Virology|July 9, 2011
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral stateHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
The Journal of Infectious Diseases|June 16, 2011
Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric miceMasataka Tsuge, Shoichi Takahashi, Nobuhiko Hiraga, et al.
Gut|November 12, 2010
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapyC Nelson Hayes, Mariko Kobayashi, Norio Akuta, et al.
Journal of Medical Virology|May 9, 2015
Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapySatoshi Yoshimi, Michio Imamura, Eisuke Murakami, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virusNobuhiko Hiraga, Hiromi Abe, Michio Imamura, et al.
Journal of Virology|August 7, 2015
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG MiceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Pageof 17